PadoveseP., GallieniM., BrancaccioD.Trace elements in dialysis fluids and assessment of the exposure of patients on regular hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis.Nephron1992; 61: 442–8.
VlassaraH.Advanced nonenzymatic tissue glycosilation: Cell-mediated interactions implicated in the complications associated with diabetes and aging.Blood Purif1990; 8: 223–32.
4.
CarozziS., NasiniM., SchelottoM.G.Effects of Ca++ and 1,25(OH)2 D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients.Adv Perit Dial1989; 5: 111–20.
5.
VeechR.L.The toxic impact of parenteral solutions on the metabolism of cells: A hypothesis for physiological parenteral therapy.Am J Clin Nutr1986; 44: 519–51.
6.
SchambyeH.T., FlesnerP., PedersenR.E.Bicarbonate-based versus lactate-based CAPD fluids -a biocompatibility study in rabbits.Perit Dial Int1992; 12: 281–6.
AebischerP., SaskenH., GallettiP.M.Effect of an ultralow temperature isotropic carbon coating on intraperitoneally implanted polyethylene tubes.Trans Soc Biomater1986; 9: 195–8.
